ClinicalTrials.Veeva

Menu

Comparative Study of the Protein C Pathway in Septic and Non Septic Patients With Organ Failure

A

Assistance Publique - Hôpitaux de Paris

Status

Terminated

Conditions

Organ Failure
Severe Sepsis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a comparative study performed in 3 groups of patients/subjects: 30 severe sepsis patients, 30 non-septic patients with organ failure, 30 healthy subjects.

The only intervention is a venous blood sampling at the onset of the disease.

The purpose of the study is to compare the PC pathway and expression and inflammatory genes between the 3 groups. The main hypothesis is that systemic inflammatory response and exacerbated coagulation activation are non specific of an infection as a triggering event.

Full description

analysis of the PC pathway

  • PC activity
  • PS activity
  • soluble thrombomodulin
  • soluble EPCR
  • activated protein C
  • quantitative flow cytometry on monocytes (thrombomodulin and EPCR)
  • whole blood mRNA (Tissue factor, thrombomodulin and EPCR)
  • inflammatory gene expression analysis by MLPA

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • severe sepsis patients or:
  • non-septic acute organ failure patients or:
  • healthy subjects matched for age and sex with severe sepsis patients

Exclusion criteria

  • criteria for organ failure lasting for more than 24 hours

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems